Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bioshares Biotech Products (BBP)

Bioshares Biotech Products (BBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BioShares
  • Assets Under Management 26,000,700
  • Shares Outstanding, K 500
  • 60-Month Beta 1.00
Trade BBP with:
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.07 (0.14%)
  • Most Recent Dividend 0.072 on 12/20/17
  • Management Fee 0.79%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.63 +6.93%
on 08/19/21
53.54 -2.88%
on 09/02/21
+2.37 (+4.78%)
since 08/16/21
3-Month
48.63 +6.93%
on 08/19/21
54.94 -5.34%
on 06/25/21
-1.19 (-2.23%)
since 06/16/21
52-Week
46.16 +12.65%
on 09/25/20
61.39 -15.30%
on 02/09/21
+3.60 (+7.43%)
since 09/16/20

Most Recent Stories

More News
The Zacks Analyst Blog Highlights: ITB, BBP, XSD, PRN, XRT

The Zacks Analyst Blog Highlights: ITB, BBP, XSD, PRN, XRT

XRT : 94.25 (+1.41%)
ITB : 70.40 (+1.06%)
PRN : 101.68 (-0.27%)
XSD : 208.62 (+0.65%)
BBP : 52.00 (+0.79%)
Beyond Clean Energy, 5 Sector ETFs Soaring to Record Highs

As most corners of the market rallied on the slew of positive news, a few sectors scaled new highs. We have highlighted five ETFs from different sectors that hit all-time highs in the recent trading session....

XRT : 94.25 (+1.41%)
ITB : 70.40 (+1.06%)
PRN : 101.68 (-0.27%)
XSD : 208.62 (+0.65%)
BBP : 52.00 (+0.79%)
4 ETFs to Play the Hot Events of Q4

The S&P 500 posted its best third-quarter gains since 2010 with an advancement of 8.5%. The gains could continue as the October-December period is normally gainful for the market.

PBW : 79.47 (-1.30%)
BBP : 52.00 (+0.79%)
ONLN : 69.49 (+0.43%)
CLOU : 30.57 (+0.66%)
Top-Performing ETFs of the Worst September Since 2011

After a superb August, September turned gloomy for Wall Street.

TAN : 83.19 (-1.14%)
DXJS : 47.61 (+0.60%)
BBP : 52.00 (+0.79%)
IPO : 69.22 (+1.48%)
TAPR : 93.01 (+12.06%)
5 ETFs Shining Bright Amid September Selling

The combination of lofty valuation, lack of additional fiscal stimulus package, election uncertainty and rising U.S.-China tensions weighed on investors' sentiment.

TAN : 83.19 (-1.14%)
BBP : 52.00 (+0.79%)
IPO : 69.22 (+1.48%)
BETZ : 31.67 (+1.77%)
EDUT : 11.54 (+1.23%)
"Worst September in 18 Years"? 4 Sector ETFs Surviving Selloffs

After a superb August, September looks gloomy for Wall Street. Still,

BBP : 52.00 (+0.79%)
PBD : 29.32 (-0.81%)
RTM : 165.54 (-0.90%)
DKNG : 59.97 (+0.22%)
BETZ : 31.67 (+1.77%)
IBBJ : 30.48 (+0.53%)
A Guide to Biotech ETF Investing

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

SBIO : 46.58 (+0.51%)
BBP : 52.00 (+0.79%)
BTEC : 56.67 (+0.44%)
BBH : 216.75 (+0.68%)
XBI : 131.00 (+0.44%)
IBB : 172.51 (+0.41%)
FBT : 172.78 (+0.28%)
CNCR : 30.65 (-0.87%)
PBE : 76.65 (+0.34%)
ARKG : 81.48 (+0.37%)
Biotech Tops in November: Best ETFs & Stocks

The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.

CNCR : 30.65 (-0.87%)
BBC : 47.89 (+0.61%)
BBP : 52.00 (+0.79%)
GBT : 26.35 (+1.46%)
PTI : 1.1100 (-3.48%)
VRTX : 187.10 (-0.93%)
CLVS : 4.61 (+3.60%)
MYOV : 22.18 (+1.60%)
CNST : 33.99 (+0.06%)
KRTX : 115.51 (+0.68%)
CRSP : 117.42 (+0.14%)
ARKG : 81.48 (+0.37%)
GNOM : 23.48 (+0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The BioShares Biotechnology Products Fund seeks investment results that correspond to the performance of the BioShares Biotechnology Products Index. Products stage companies are typically more established companies with much clinical trial failure risk behind them.

See More

Key Turning Points

3rd Resistance Point 52.00
2nd Resistance Point 52.00
1st Resistance Point 52.00
Last Price 52.00
1st Support Level 52.00
2nd Support Level 52.00
3rd Support Level 52.00

See More

52-Week High 61.39
Fibonacci 61.8% 55.58
Fibonacci 50% 53.78
Last Price 52.00
Fibonacci 38.2% 51.98
52-Week Low 46.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar